Authors
Latest:
COUNTERPOINT: Gun Control and the Second AmendmentWe are told that we must allow the massacre of innocent Americans--including children--with easily obtained firearms because "it is the price we must pay for freedom."
Latest:
Edema Associated With Infarct . . . Or Something Else?A sharp decrease in visual acuity affecting both eyes developed in a 35-year-old man 3 days after elective abdominal surgery. Six months earlier, acute B cell-type lymphoblastic leukemia was diagnosed in the patient for which he received bone marrow transplantation (BMT). Following BMT, graft-versus-host disease developed in the patient. It was treated with cyclosporine, mycophenolate mofetil (CellCept), sirolimus (Rapamune), and prednisone.
Latest:
How Serious Are We About Psychiatric Disease?Psychiatric treatment requires primary intervention and solid follow-up care, like diabetes, hypertension, and other medical conditions. More in this commentary by a resident in psychiatry.
Latest:
Treating Complex Trauma SurvivorsThis CME outlines distinguishing features of PTSD, complex trauma, and the dissociative subtype of PTSD (DPTSD), with an explanation of the distinctive neurobiological subtype of DPTSD.
Latest:
A Visit to Auschwitz: Reflections on Biology and the Psychiatric Sequelae of Political ViolenceIf I closed my eyes, it would have been easy to imagine that I was visiting a peaceful city park. The sounds of birdsong and children’s laughter rang in the air, and the odor of freshly cut grass filled my nostrils. But the sweet smells and soothing sounds belied the horror of the place where I actually stood-inside the wrought iron gates of Auschwitz-Birkenau, the Holocaust’s most infamous concentration camp. Today the camp is a museum, and there is an eerie dissonance between the tranquility of its sprawling grounds and the mass murders that were carried out here almost 70 years ago. Like many visitors to Auschwitz, I experienced powerful emotions-a mixture of revulsion, anger, and a deep empathy for the millions of souls who suffered and perished there. I also felt a discomfiting sense of doubt about the goodness of humanity, including my own.
Latest:
Sexual Harassment and Alcohol UseSince the 1990s there has been an increase in research on sexual harassment and its mental health consequences. These researchers discuss the use of alcohol to self-medicate harassment-engendered distress and the need for greater attention to potential alcohol-related consequences of harassment experiences.
Latest:
The Trauma-Focused CBT and Family Acceptance Project: An Integrated Framework for Children and Youth"Well-meaning" behavior by parents or guardians could be contributing to high levels of depression, suicidality, substance use, and other adverse outcomes in their child.
Latest:
Antipsychotics for Behavioral Disturbance in Dementia? A Clinical ConundrumAlthough the adverse-effect profile of older, conventional (typical) antipsychotics has discouraged many clinicians from using them, they remain widely used in elderly patients with dementia.
Latest:
Off-Label PrescribingMedications cannot be marketed in the United States without an FDA determination that they are safe and effective for their intended use. To obtain such certification, pharmaceutical companies submit their products to rigorous scrutiny (eg, in vitro studies, animal studies, human clinical trials) and present the subsequent data to the FDA, which determines whether the medication in question is safe and effective for a specific purpose.
Latest:
E-Cigarettes, Vaping, and Other Electronic Nicotine Products: Harm Reduction Pathways or New Avenues for Addiction?This article summarizes data on e-cigarettes, provides recommendations and resources to learn more, and emphasizes the evidence for treating tobacco (traditional cigarettes) addiction in people with mental illness.
Latest:
The Use of Meditation in Children With Mental Health IssuesThis review provides information to assist clinicians who are considering mindfulness meditation for their patients.
Latest:
Accepting Patients as They Are: The Joys and Pains of Street RoundsA recent experience on street rounds offered a moment that brought this psychiatrist back to one of the main reasons she chose psychiatry as a profession.
Latest:
CBT in 2023: Current Trends in Cognitive Behavior TherapyWhere does CBT stand today, nearly 60 years after its inception?
Latest:
Anxiety Treatment at Your FingertipsKey questions to consider when evaluating a digital therapeutic for anxiety.
Latest:
Autism, Pregnancy, and SSRIs: When the Media Distorts the FactsSetting the record straight on the burgeoning field of reproductive psychiatry.
Latest:
Contraception and MisconceptionsPsychiatrists who treat women and adolescent girls may find it necessary to discuss with their patients reproductive planning and the role of contraception in setting comprehensive treatment goals. Here's why.
Latest:
Enlisting Family Members to Address Treatment Refusal in Substance AbusersAnyone who is close to someone who abuses alcohol or drugs knows all too well that substance abusers do not typically seek treatment until they have experienced years of substance-related problems. During the first year after onset of a diagnosable substance use disorder, only 1 of 5 alcohol-dependent persons and 1 of 4 drug-dependent persons receive treatment.
Latest:
Gene Mutation Can Raise Risk of Alcohol and Drug AbuseAn interplay between genetic and early environmental factors contributes to the development of substance abuse.
Latest:
The Role of Estrogen in the Development of Age-Related Cognitive Impairment and DementiaDuring and after menopause, many women report impairments in cognitive functioning. Should hormones be prescribed in an effort to mitigate cognitive symptoms of menopause?
Latest:
QTc Prolongation Associated With Psychotropics: Therapeutic ConsiderationsA focus on QTc monitoring in patients receiving psychotropics, especially when multiple medications are prescribed.
Latest:
Treating Late-Life AnxietyDespite high prevalence and negative consequences of anxiety disorders in later life, this area has received little research attention. A relatively small number of outcome investigations on late-life anxiety have focused on the impact of pharmacological and psychotherapeutic treatments.
Latest:
Antidepressant Use in Children With CancerIn 2007, cancer was diagnosed in 10,400 children and adolescents under the age of 15 years.1 While cancer remains the second leading cause of death in children, increasing numbers of children with cancer are surviving into adulthood.2 Over the past 30 years, 5-year survival rates for children with cancer have significantly improved, from 59% in 1975 to 1977 to 80% in 1996 to 2004.3 Pediatric cancer, increasingly considered a chronic rather than an acute condition, is an intense emotional and physical experience for patients and their families.4
Latest:
Depression and Cardiovascular DiseaseDepression is a risk factor for cardiovascular disease and death in many ways, directly and indirectly. It is independently linked to smoking, diabetes, and obesity-all of which are risk factors for coronary heart disease (CHD).1 Depressed patients are more likely to be noncompliant with treatment recommendations, including diet, medications, and keeping appointments, and are more likely to delay presentation for treatment with an acute coronary event.2-4
Latest:
What Are Common Comorbidities in ADHD?In this article, Julie Sherman, PhD and Jay Tarnow, MD briefly discuss the latest research findings on ADHD.
Latest:
Frontiers in Psychiatric ResearchThese are exciting times for genetics research: Science magazine chose our new appreciation of human genetic diversity as the scientific breakthrough of the year 2007.1 The year brought a new genetic bonanza with the announcement of the 1000 Genome Project, a plan to capture human diversity by obtaining the entire genome sequence information of 1000 individuals.
Latest:
Stroke: While Current Treatment Is Limited, New Options Are on the HorizonCurrent therapy for acute ischemic stroke remains limited to intravenous recombinant tissue plasminogen activator (tPA) administered within 3 hours of symptom onset, but despite strong evidence supporting its effectiveness,1-5 only 2% to 4% of all stroke patients currently receive tPA.
Latest:
On the Loss of a Dear FriendDr Wayne Katon (1950-2015) revolutionized care for patients around the world.
Latest:
Diagnostic Utility of the Subjective Peripheral Neuropathy Screen in HIV-Infected PatientsHIV/AIDS, peripheral neuropathy, sensory neuropathies, subjective peripheral neuropathy screen
Latest:
Use of a Nasal Naloxone-Containing Kit in the Transition From Regional Psychiatric Hospital to Community Care: A 1-Year Follow-up StudyDetails here about a protocol for opioid abusers and the mentally ill that helped avoid deaths from drug overdose after psychiatric hospitalization.
Latest:
A Dog Says "Thank You"The human-animal relationship can provide insight into the patient’s ability to connect, to interact, and to show care and empathy. Plus, companion animals tend not to breach confidentiality.
